Browse study websites

Discover. Prevent. Cure.

Menu Fundraise Donate

    Recommended pages

      Do you mean

        25-36 of 1130 results for 'vaccine'

        Refine research

        Research

        Safety surveillance of influenza vaccine in pregnant women

        Vaccination is the most effective strategy for preventing influenza infection in pregnancy. ...

        Research

        FluBubs: Safety and immunogenicity of Early Quadrivalent Influenza Vaccine

        Christopher Tobias Blyth Kollmann CC TK MBBS (Hons) DCH FRACP FRCPA PhD PhD, M.D., SFUW Director, Wesfarmers Centre of Vaccines and Infectious Diseases; Co-Head, Infectious Diseases Epidemiology, Wesfarmers Centre of Vaccines and Infectious Diseases ...

        Research

        A DTPa-HBV-IPV vaccine for primary vaccination of infants

        Combined vaccines have an increasingly important role to play in delivering these antigens acceptably. ...

        Research

        Genetic Variants in the IL-4/IL-13 Pathway Influence Measles Vaccine Responses and Vaccine Failure in Children from Mozambique

        We investigated IL-4, IL-13, and IL-4Rα polymorphisms and their impact on measles IgG responses and measles vaccine failure, in two separate cohort. ...

        Research

        Impact of CD14 promoter variants on measles vaccine responses and vaccine failure in children from Australia and Mozambique

        Host genetics are likely to play a crucial role, particularly variants that alter key innate immune response genes. ...

        Research

        Testing the meningococcal conjugate vaccine MenACWY-TT in toddlers

        Jennifer Peter Kent Richmond J PC RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@telethonkids.org.au Clinical Research Manager Head, Vaccine Trials Group Jennifer completed her Diploma of Nursing in 1986 at ...

        Research

        Immunological mechanisms of vaccine-induced protection against COVID-19 in humans

        Most COVID-19 vaccines are designed to elicit immune responses, ideally neutralizing antibodies (NAbs), against the SARS-CoV-2 spike protein. Several vaccines, including mRNA, adenoviral-vectored, protein subunit and whole-cell inactivated virus vaccines, have now reported efficacy in phase III trials and have received emergency approval in many countries. ...

        Research

        Strep A: challenges, opportunities, vaccine-based solutions and economics

        Streptococcus pyogenes (Strep A) is a leading cause of morbidity and mortality across the globe, annually causing hundreds of millions of cases of disease. ...

        Research

        Polymorphisms in key innate immune genes and their effects on measles vaccine responses and vaccine failure in children from Mozambique

        Despite an effective vaccine, measles remains a major health problem globally, particularly in developing countries. More than 30% of children show primary... ...

        Research

        Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children.

        Deborah Lehmann D AO, MBBS, MSc Honorary Emeritus Fellow Honorary Emeritus Fellow Authors: Jayasinghe S, Chiu C, Menzies R, Lehmann D, Cook H, Giele C, et al. Authors notes:  Vaccine. 2015;33(48):6666-74. Keywords: Pneumococcal disease, Pneumococcal ...

        Research

        Immunogenicity and Immune Memory after a Pneumococcal Polysaccharide Vaccine Booster in a High-Risk Population Primed with Pneumococcal Conjugate Vaccine

        PPV is immunogenic in 9-month-old children at high risk of pneumococcal infections and does not affect the capacity to produce protective immune responses ...

        Research

        Clinical development strategy for a candidate group A streptococcal vaccine

        This review outlines a clinical development strategy detailing the phases of development required for registration of a candidate Group A streptococci vaccin ...

        Page 3 of 95